Skip to main content
Hsu RK, Phoenix J, Sinclair GI, Gupta SK, Puga A, Nguyen K, Schubert CK, Merrill D, Richardson D, Nelson K, Reynolds M, Zografos L, Jean-Louis A, Garris C. US Healthcare Provider Perspectives on the initiation of cabotegravir and rilpivirine long-acting (CAB+RPV LA) in an observational real-world study (BEYOND). Poster presented at the IDWeek 2022 Conference; October 21, 2022. Washington, DC.
Zografos L, Calingaert B, Wolin D, Andrews E, Davis K, Nelson K, Lenz Y, Tarenz C, Horvat-Broecker A, Suzart-Woischnik K. Evaluating physician knowledge of risks and safe use of rivaroxaban. Poster presented at the Virtual ICPE 2021 Conference; August 23, 2021.